TDOC Stock Surpasses 200-DMA With Conviction After Walmart Partnership – BofA Sees Its Expanded Distribution As 'Modest Positive'

• Teladoc partnered with Walmart to offer virtual urgent care, dermatology, and nutrition services through the Better Care Services platform.
• BofA views the expanded distribution as a "modest positive" that connects Teladoc with a new uninsured or underinsured demographic.
• Teladoc said that, if needed, prescriptions can be sent to any pharmacy, including Walmart.

Shares of Teladoc Health (TDOC) rose over 7% on Thursday, surpassing its 200-day moving average after the company announced its services are now available through Walmart's Better Care Services platform.

TDOC Walmart Partnership

Teladoc said the partnership with Walmart will enable the company to launch its range of offerings, including 24/7 virtual urgent care for common conditions, dermatology consultations with a 24-hour turnaround, and one-on-one nutrition coaching for customers. 

These services will be provided to Walmart customers seeking both insured and cash-pay options. The price per visit would be $89, Teladoc noted. 

The firm also added that prescriptions, if needed, can be sent to any pharmacy, including Walmart, where same-day delivery in as fast as an hour is available, with free delivery for Walmart+ members.

Better Care Services is Walmart's platform launched in January 2026 that integrates third-party telehealth providers with the retailer's existing pharmacy infrastructure. This follows Teladoc's January launch of its BetterHelp mental health offering on the same Walmart platform.

"Walmart is where millions of Americans already go for everyday needs, and now, getting care from Teladoc Health can be part of that same experience," said Kelly Bliss, President of U.S. Group Health at Teladoc Health.

The company stated that the Walmart partnership is the latest step in its push to embed its services with retailers and platforms Americans already use.

BofA Says Partnership with Walmart 'Modest Positive' For TDOC’s Distribution

Bank of America(BofA) noted that Teladoc’s partnership with Walmart will expand the reach of Teladoc’s core medical network to the uninsured or underinsured demographic, and that the firm sees it as a ‘modest positive’ for Teladoc, according to TheFly.

However, the firm does not expect Teladoc to have a notable impact on financials in the near term. BofA maintains a ‘Buy’ rating with a $9 price target on the stock.

What Retails Thinks About TDOC

The retail sentiment surrounding the stock has improved to ‘neutral’ from ‘bearish’ while message volumes remained ‘low’ over the past 24 hours.

Teladoc Health shares have gained marginally so far this year.

For updates and corrections, email newsroom[at]stocktwits[dot]com.

Read Next: SMCI's Collaboration With Taiwanese Authorities Leads To Arrests — A Look At Jensen Huang's Advice To Super Micro